Startups
2010
IMMUNNOVATIVE DEVELOPMENTS SLDevelopment of biological drugs for the treatment of immune-based inflammatory diseases
Company ceased activity
Company ceased activity
Address
Carrer de Baldiri Reixac 4-8, 08028 Barcelona, Spain
CERCA ownership
Other Catalan Public owners
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Product description
ImmunNovative developments products have been shown to be effective in recognizing bacteria and fungi.
They are "first in class" products, with a broad spectrum of action and that do not generate resistance against pathogens. They do not have toxicity or immunogenicity. Proof of concept has been demonstrated in relevant animal models, with strong intellectual property protection with scope for expansion and improvement.
They are "first in class" products, with a broad spectrum of action and that do not generate resistance against pathogens. They do not have toxicity or immunogenicity. Proof of concept has been demonstrated in relevant animal models, with strong intellectual property protection with scope for expansion and improvement.
Company Closed or Exit Year